右美托咪定联合纳布啡对妇科老年腹腔镜手术病人应用价值

    The application value of dexmedetomidine combined with nalbuphine in gynecological elderly patients undergoing laparoscopic surgery

    • 摘要:
      目的: 探讨右美托咪定联合纳布啡对妇科老年腹腔镜手术病人应用价值。
      方法: 纳入预行腹腔镜手术的老年病人,分为对照组和联合组,各55例;联合组给予盐酸右美托咪定和盐酸纳布啡,对照组病人同步给予等量0.9%氯化钠溶液和盐酸纳布啡。比较2组心率(HR)、平均动脉压(MAP)、苏醒期躁动评分、简易精神状态检查表(MMSE)评分、Ramsay评分、蒙特利尔认知评估量表(MoCA)、细胞免疫功能及2组术后不良反应发生率。
      结果: 手术完毕(T2)时联合组HR显著低于对照组,气管插管后即刻(T1)、T2时联合组MAP显著低于对照组(P < 0.05);术后24 h、72 h,2组MMSE、MoCA评分均低于术前,且联合组高于对照组(P < 0.05);术后72 h,2组MMSE、MoCA评分均高于术后24 h(P < 0.05);联合组躁动发生率为23.63%显著低于对照组54.54%(P < 0.05);术后各时间点联合组Ramsay评分均显著高于对照组(P < 0.05)。术后24 h、术后72 h 2组CD3+、CD4+、CD8+、CD4+/CD8+、NK细胞均有明显变化,且术后24 h、72 h时联合组以上指标改善优于对照组(P < 0.05)。联合组与对照组不良反应总发生率比较无统计学差异(P > 0.05)。
      结论: 右美托咪定联合纳布啡辅助麻醉应用于妇科老年腹腔镜手术可达到满意的镇静效果,有效抑制病人术中应激反应,对病人术后早期认知功能、苏醒期躁动以及免疫功能具有积极的作用,且安全性较高。

       

      Abstract:
      Objective To investigate the value of dexmedetomidine combined with nalbuphine in gynecological senile patients undergoing laparoscopic surgery.
      Methods The elderly patients who underwent laparoscopic surgery were divided into control group (n = 55) and the combined group (n = 55). The combined group was given dexmedetomidine hydrochloride and nalbuphine hydrochloride, while the control group was given the same amount of normal saline and nalbuphine hydrochloride simultaneously. The heart rate (HR), mean arterial pressure (MAP), score of restlessness during recovery, Mini-Mental State Examination (MMSE) score, Ramsay score, montreal cognitive assessment (MoCA), cellular immune function and compare the incidence of postoperative adverse reactions between two groups of patients.
      Results At the end of the operation (T2), the HR of the combined group was significantly lower than that of the control group, and the MAP of the combined group was significantly lower than that of the control group immediately after tracheal intubation (T1) and T2 (P < 0.05); at 24 h and 72 h after operation, the MMSE, MoCA score of both groups were lower than those before operation, and the combined group was higher than that of the control group (P < 0.05); at 72 hours after operation, the MMSE, MoCA score in both groups was higher than at 24 hours after operation (P < 0.05); the incidence of restlessness in the combined group was 23.63%, which was greatly lower than that in the control group (54.54%) (P < 0.05); at all postoperative time points, the Ramsay score of the combined group was significantly higher than that of the control group (P < 0.05). There were significant changes in CD3+, CD4+, CD8+, CD4+/CD8+ and NK cells between the two groups at 24 h and 72 h after operation, and the improvement of the above indexes in the combined group was better than that in the control group at 24 h and 72 h after operation (P < 0.05). The total incidence of adverse reactions in the combined group and the control group were 12.73% and 18.18%, respectively, with no statistical difference (P > 0.05).
      Conclusion Dexmedetomidine combined with nalbuphine can achieve satisfactory sedation effect in elderly patients undergoing gynecological laparoscopic surgery, effectively inhibit the intraoperative stress response of patients, and has a positive effect on early postoperative cognitive function, restlessness during recovery and immune function of patients, with high safety.

       

    /

    返回文章
    返回